Streetbeat News

Products Services

PGY

Pagaya Technologies LTD. (NASDAQ:PGY) announced an agreement to purchase 100% of Theorem Technology, Inc., a consumer credit funds manager. The acquisition, expected to close in Q4 2024, will bring Theorem's fund management and engineering capabilities to Pagaya, enhancing its funding diversification and capital efficiency. The deal is anticipated to be accretive in 2025.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:32 pm

MLSS

Milestone Scientific has received multiple Notices of Allowance for key patent applications in the U.S. and Europe, advancing their painless and precise drug delivery instruments.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:32 pm

PESI

Perma-Fix Environmental Services has acquired an Environmental Waste Operations Center near Oak Ridge, TN. The company plans to upgrade the facility for decontamination projects, waste processing, and PFAS capabilities.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:30 pm

EA

MSFT

SONY

WBD

SAG-AFTRA has initiated a strike affecting video game work under its Interactive Media Agreement, targeting companies like Microsoft’s Activision Blizzard, Electronic Arts, Sony’s Insomniac Games, and Warner Bros. Discovery’s WB Games. The strike is driven by concerns over AI protections.

Portfolio Pulse from Franca Quarneti

July 30, 2024 | 12:25 pm

XPEV

XPeng Aeroht, affiliated with XPeng Inc (NYSE:XPEV), has partnered with GAMECO to establish an after-sales service system for flying cars. This collaboration aims to enhance the performance and safety of low-altitude air travel by covering maintenance, component manufacturing, engineering services, and training. XPeng Aeroht has developed five generations of eVTOLs and plans to start pre-sales of its next-generation modular flying car at the Guangzhou Auto Show in November.

Portfolio Pulse from Anan Ashraf

July 30, 2024 | 12:24 pm

SAVA

Cassava Sciences (NASDAQ:SAVA) announced an extension of its open-label extension trials for simufilam in Alzheimer's disease by up to 36 months. This allows participants to continue treatment pending the results of ongoing Phase 3 trials. The company will also add cognition and plasma biomarker monitoring to gather additional long-term data.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:19 pm

NKGN

NKGen Biotech presented new data on their SNK01 product at the 2024 AAIC, showing it can reduce α-synuclein levels in Alzheimer's patients' CSF and improve cognitive function. This is significant as increased α-synuclein is linked to worse cognitive performance and is not targeted by current treatments.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:17 pm

COMM

CommScope has launched the STARLINE 1.8 GHz ESD Amplifiers for DOCSIS 3.1 networks, providing an upgrade path to DOCSIS 4.0. The new amplifiers offer easy installation and significant performance enhancements.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:17 pm

ATYR

aTyr Pharma (NASDAQ:ATYR) has entered into a research agreement with Stanford Medicine to study the mechanisms of immunosuppression in glioblastoma multiforme (GBM). Dr. Michael Lim, Chair of the Department of Neurosurgery at Stanford Medicine, will lead the study.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:14 pm

EOLS

Evolus, Inc. (NASDAQ:EOLS) has launched its product Nuceiva® in Australia as part of its global expansion strategy. The company has established Evolus Australia to handle medical education, training, marketing, and sales for medical aesthetics professionals.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:14 pm